DIA 48th Annual Meeting
Click here to go to the previous page
Companion Diagnostics: Current and Future Developments
Track : Track 09: Medical Diagnostics and Devices
Program Code: 112
Date: Monday, June 25, 2012
Time: 10:00 AM to 11:30 AM  EST
CHAIR :
Paul Van Dongen, NautaDutilh N.V., Netherlands
PRESENTER (S):
Paul Van Dongen, NautaDutilh N.V., Netherlands
 Jeffrey Stuart, Novartis Pharmaceuticals Corporation, United States
 Barry Sall, PAREXEL Consulting, United States
Description
Companion diagnostics, in vitro diagnostics that accompany treatments, are a major development in personalized medicine. This session looks into the regulatory and scientific aspects of this innovative approach.

Learning Objectives:
Recognize the impact of companion diagnostics on treatment
Discuss the regulatory thinking in respect of combinations of diagnostics and treatments.